Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Black Diamond Therapeutics (BDTX)

Annual Return

Over the past 3 years, BDTX has had an average annual return of -3.56%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, BDTX has had an average annual return of -30.28%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Jan 30, 2020, BDTX has had an average annual return of -37.02%, underperforming the benchmark SPY, which returned +15.68% annual.

2026202520242023202220212020
-13.64%+13.65%-23.88%+56.14%-66.22%-83.37%-18.82%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+2.44%-0.79%-13.74%+24.26%-16.24%-5.34%-13.64%
2025+22.51%-23.34%-22.79%+9.67%+29.23%+12.75%+7.32%+3.41%+37.73%+2.08%-1.22%-36.36%+13.65%
2024+36.66%+33.92%-1.46%+9.89%-14.17%-2.56%+30.76%+0.13%-28.67%-37.02%-3.31%-19.23%-23.88%
2023+66.67%-41.05%+6.92%-24.43%+30.11%+171.55%-26.11%-9.63%-14.87%-34.53%+24.58%+20.07%+56.14%
2022-21.78%-24.72%-11.70%-12.25%-30.52%+45.56%+42.38%-8.91%-47.03%+36.68%-8.72%-14.61%-66.22%
2021-22.71%+13.04%-13.35%+9.81%-50.76%-7.07%-21.60%+5.66%-16.22%-9.47%-21.65%-11.18%-83.37%
2020-5.02%-28.03%-7.55%+48.45%+5.43%+7.97%-34.01%+3.41%+5.08%+4.23%+5.81%-3.87%-18.82%

Drawdown analysis of Black Diamond Therapeutics (BDTX)

The maximum drawdown for the BDTX was -97.21%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current BDTX drawdown is -95.31%.

Since Jan 30, 2020 BDTX has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-97.21%Jun 22, 20201205Apr 8, 2025OngoingOngoingOngoing
-53.95%Jan 30, 202033Mar 18, 202026Apr 24, 202059
-19.84%May 12, 202022Jun 12, 20206Jun 22, 202028
-17.80%Apr 27, 20204May 1, 20205May 8, 20209